ArticlePediatric rheumatology online journal2026

Anti-adalimumab antibodies are associated with loss of response in juvenile idiopathic arthritis.

Mikhail Carrim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.